5-Amino-1MQ: NNMT and Skeletal Muscle Research

Scope: NNMT Inhibition in Laboratory Research

5-Amino-1MQ is a small molecule discussed in nicotinamide N-methyltransferase (NNMT) inhibition research. Its relevance to skeletal muscle research concerns experimentally testable relationships among enzyme activity, nicotinamide metabolism, and cellular phenotype. These relationships should not be presented as established muscle-preservation effects of a commercial material.

This article focuses on chemical identity, experimental interpretation, and laboratory documentation. Alpha Carbon Labs supplies materials solely for nonclinical laboratory research.

Chemical Identity: A Small Molecule, Not a Peptide

5-Amino-1MQ refers to 5-amino-1-methylquinolinium. It is not a peptide, and peptide synthesis or peptide purity terminology should not be used to characterize it. The abbreviated name alone does not establish the counterion, hydration state, formulation, or composition of a particular material.

Before experimental use, confirm the chemical form against the lot-specific documentation. Molecular-weight calculations and interpretation of analytical results must correspond to the documented form, rather than an assumed salt. No lot-specific identity, purity, potency, or selectivity results were supplied for this article.

What NNMT Does—and What Its Inhibition Does Not Establish

NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine to nicotinamide, producing 1-methylnicotinamide and S-adenosylhomocysteine. This reaction connects nicotinamide metabolism with methyl-donor metabolism. NNMT does not directly consume NAD+.

NAD+ is a redox cofactor and a substrate for NAD+-consuming enzymes, rather than simply a cellular fuel. Changes in NNMT activity do not, by themselves, establish the direction or magnitude of a change in cellular NAD+. Nicotinamide availability, salvage-pathway activity, NAD+ consumption, and the experimental system all affect interpretation.

In animal research, Kraus et al. (2014) investigated Nnmt knockdown in mice under high-fat-diet conditions [1]. That experimental approach concerns reduced gene expression, not direct evidence for the activity of an Alpha Carbon Labs 5-Amino-1MQ lot. Genetic knockdown and small-molecule inhibition must be distinguished because they need not produce equivalent biological effects.

Interpreting Evidence Relevant to Skeletal Muscle

Evidence should remain attached to the system in which it was generated. An enzyme assay can address biochemical inhibition; a cultured-cell experiment can address a cellular response; and an animal experiment can address tissue-level endpoints within that model. None can be substituted for another without additional evidence.

Evidence types and their interpretation limits

Evidence type	Relevant question	Interpretation limit
Purified-enzyme assay	Does the tested material alter measured NNMT activity?	Does not establish cellular uptake, selectivity, or a muscle-tissue effect.
In-vitro muscle-cell model	Are target-related measurements associated with a defined cellular phenotype?	Does not establish whole-organism muscle preservation.
Animal experiment	What tissue-level findings occur in the specified species and experimental conditions?	Does not establish human effects or veterinary suitability.
In-silico analysis	What interactions or pathways does a computational model predict?	Predictions require experimental validation.
Human study	What was measured in the specified study population?	Findings cannot be transferred to a different compound, formulation, population, or supplier's material without supporting evidence.

For a skeletal-muscle study, report the species or cell source, cell differentiation state, experimental perturbation, comparator, sampling interval, and measured endpoint. Muscle-cell viability, stem-cell behavior, fiber morphology, tissue mass, and contractile function are distinct outcomes. A change in one does not establish a change in the others.

Myostatin: A Separate Experimental Question

Myostatin is involved in the regulation of skeletal muscle growth. However, the phrase “myostatin flux” does not identify a defined assay or endpoint in the supplied article. No direct evidence was supplied establishing that 5-Amino-1MQ changes myostatin production, processing, receptor signaling, or downstream signaling in a specified model.

A proposed connection between NNMT inhibition and myostatin signaling therefore remains a question to test, not an established mechanism. Measurements of NAD+ or general cellular metabolism alone cannot demonstrate an effect on myostatin signaling or muscle protein turnover.

Designing Interpretable Nonclinical Experiments

The following are experimental-planning considerations, not reported findings from the cited papers or validated protocols for an Alpha Carbon Labs product:

• Separate target activity from downstream effects. Measure NNMT activity or an appropriately validated target-related readout rather than inferring inhibition solely from a change in cell phenotype.
• Define the metabolic measurements. Distinguish NAD+, NADH, their ratio, and total pool measurements. Record normalization methods and sample-processing conditions.
• Use suitable controls. Include matched vehicle controls and assess whether the material interferes with the analytical detection method.
• Evaluate cellular confounding. In cell-based work, measure viability and cell number so that loss of cells is not misinterpreted as a pathway-specific effect.
• Distinguish perturbation methods. Treat gene knockdown and pharmacological inhibition as separate experiments. Agreement can support a hypothesis but does not independently establish compound selectivity.
• Prespecify muscle-related endpoints. Define the actual measurement rather than using broad labels such as “muscle protection” or “metabolic optimization.”

Analytical Documentation and Laboratory Handling

Consult the available quality-control information and certificate-of-analysis documents for the exact lot under evaluation. Check which methods support identity and composition, whether the results are lot-specific, and what each reported value measures. Chromatographic area purity alone does not establish mass content, biological activity, sterility, or absence of every possible impurity.

This article does not establish batch-testing practices or analytical acceptance criteria. Published findings do not substitute for characterization of the material used in an experiment.

Use the material-specific safety data sheet, institutional risk assessment, and applicable laboratory procedures to determine containment, personal protective equipment, storage, spill response, and waste disposal. The supplied article provides no validated storage conditions, stability data, solubility specifications, or hazard classification; these should not be inferred from the compound's proposed mechanism.

Reading the Supplied Literature

Before using a reference to justify an experiment, check the full paper for the exact compound, chemical form, model, methods, endpoints, and limitations. A study of NNMT expression, gene depletion, NAD+ metabolism, or a different inhibitor is not automatically a study of 5-Amino-1MQ. Bibliographic details and identifier correspondence should also be checked against the source records. The supplied references are retained below without alteration; their inclusion is not verification of a product claim.

References

1. Kraus, D., et al. (2014). Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature, 508(7495), 258-262. — https://pubmed.ncbi.nlm.nih.gov/24717434/
2. Neelakantan, H., et al. (2017). Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochemical Pharmacology, 145, 111-120. — https://pubmed.ncbi.nlm.nih.gov/28919100/
3. Stromsdorfer, K. L., et al. (2016). Targeted depletion of nicotinamide N-methyltransferase in skeletal muscle protects against diet-induced obesity. Journal of Biological Chemistry, 291(44), 22971-22983. — https://pubmed.ncbi.nlm.nih.gov/27566543/
4. Roessler, C., et al. (2014). Nicotinamide N-methyltransferase enhances the capacity of the salvage pathway and promotes NAD+ synthesis. FEBS Letters, 588(17), 2843-2850. — https://pubmed.ncbi.nlm.nih.gov/25026046/
5. Gomes, A. P., et al. (2013). Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell, 155(7), 1624-1638. — https://pubmed.ncbi.nlm.nih.gov/24360282/
6. Canto, C., et al. (2015). NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metabolism, 22(1), 31-53. — https://pubmed.ncbi.nlm.nih.gov/26118927/
7. Katsyuba, E., et al. (2020). De novo NAD+ synthesis enhances mitochondrial disease progression. Cell Metabolism, 31(2), 263-276. — https://pubmed.ncbi.nlm.nih.gov/31883832/
8. Camporez, J. P., et al. (2013). Cellular energy state regulates the transition of skeletal muscle from growth to atrophy. American Journal of Physiology-Endocrinology and Metabolism, 305(3), E359-E370. — https://pubmed.ncbi.nlm.nih.gov/23757404/

Limitations

Published findings are specific to the tested materials and study systems. They do not establish safety, effectiveness, approval, or suitability of material sold by Alpha Carbon Labs for human or veterinary use.